Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis

Digestive Diseases and Sciences

Volumn 51, Issue 9, 2006, Pages 1525-1531

  Sakimura, Kyoya ^a   Omori, Toshihide ^b   Iwashita, Etsuro ^c   Yoshida, Takeshi ^d   Tsuzuki, Yoshikazu ^e   Fujimori, Kenji ^f   Konishi, Fumio ^g   Yoshida, Yukio ^g   Anzai, Hiroo ^d   Suzuki, Hiromichi ^f   Sugawara, Souichi ^f   Takeda, Yuji ^h   Hiraishi, Katsuya ^h   Saniabadi, Abbi R ^h   Ide, Tatsuo ^h   Miura, Soichiro ^e   Ota, Shinichi ^f  

^a SAITAMA RED CROSS HOSPITAL   (Japan)

^b Ageo Central General Hospital   (Japan)

^c Etsuro Iwashita Gastrointestinal Tract Clinic

^d SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

^e NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

^g JICHI MEDICAL UNIVERSITY   (Japan)

^h JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Adacolumn; Clinical response; Granulocyte and monocyte adsorptive apheresis; Inflammatory bowel disease; Interleukin 1 receptor antagonist; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKAPHERESIS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, INTERLEUKIN-1; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS; TREATMENT OUTCOME;

EID: 33748626306     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-9012-1     Document Type: Article

References (30)

1. Saniabadi AR, Hanai H, Suzuki Y, Ohmori T, Sawada K, Yoshimura N, Saito Y, Takeda Y, Umemura K, Kondo K, Ikeda Y, Fukunaga K, Nakashima M, Beretta A, Bjarnason I, Lofberg R (2005) Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy? J Clin Apher 20:171-184
2. Saniabadi AR, Hanai H, Takeuchi K, Bjarnason I, Lofberg R (2003) Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7:48-59
3. Ohara M, Saniabadi AR, Kokuma S, Hirata I, Adachi M, Agishi T, Kasukawa R (1997) Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21:989-994
4. Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, Adachi M, Shimoyama T (2002) Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 47:1334-1341
5. Braddock M, Quinn A (2004) Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3:330-339
6. Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382-389
7. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346
8. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340
9. Arend WP (2002) The mode of action of cytokine inhibitors. J Rheumatol Suppl 65:16-21
10. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106:637-642
11. Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, Kollinger M, Scholmerich J, Gross V (1997) Imbalance of the interleukin 1 system in colonic mucosa - association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut 41:651-657
12. Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, Vangoidsenhoven E, Vermeire S, Rutgeerts P, Van Ranst M (2002) Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Genes Immun 3:400-406
13. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y (2000) Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191:313-320
14. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW (2000) Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 191:303-312
15. Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167-227
16. Malyak M, Smith MFJr, Abel AA, Arend WP (1994) Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 14:20-30
17. Kyogoku M, Kasukawa R (1998) Clinical and basic studies on the G-1 column, a new extracorporeal therapeutic device effective in controlling rheumatoid arthritis. Inflamm Res 47(Suppl 3):166-176
18. Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M (2003) Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 7:334-340
19. Hanai H, Watanabe F, Takeuchi K, Saniabadi AR, Bjarnason I (2003) Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study. Clin Gastroenterol Hepatol 1:28-35
20. Kashiwagi N, Hirata I, Kasukawa R (1998) A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 2:134-141
21. Hanai H, Watanabe F, Saniabadi AR, Matsushitai I, Takeuchi K, Iida T (2002) Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349-2353
22. Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298:82-86
23. Matts SG (1961) The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30:393-407
24. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR (2001) Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 16:1-9
25. Propst A, Propst T, Herold M, Vogel W, Judmaier G (1995) Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur J Gastroenterol Hepatol 7:1031-1036
26. Kuboyama S (1998) Increased circulating levels of interleukin-1 receptor antagonist in patients with inflammatory bowel disease. Kurume Med J 45:33-37
27. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K (2004) Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res 53:277-283
28. Symons JA, Young PR, Duff GW (1995) Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA 92:1714-1718
29. Burger D, Chicheportiche R, Giri JG, Dayer JM (1995) The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 96(1):38-41
30. Takeda Y, Hiraishi K, Takeda H, Shiobara N, Shibusawa H, Saniabadi AR, Adachi M, Kawata S (2003) Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood. Inflamm Res 52:287-290